Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.

Hróbjartsson A, Pildal J, Chan AW, Haahr MT, Altman DG, Gøtzsche PC.

J Clin Epidemiol. 2009 Sep;62(9):967-73. doi: 10.1016/j.jclinepi.2009.04.003.

PMID:
19635403
2.

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.

Haahr MT, Hróbjartsson A.

Clin Trials. 2006;3(4):360-5. Review.

PMID:
17060210
3.

Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.

Pildal J, Chan AW, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC.

BMJ. 2005 May 7;330(7499):1049. Epub 2005 Apr 7. Review.

4.

Assessing blinding in randomised controlled trials of acupuncture: challenges and recommendations.

Hopton AK, Macpherson H.

Chin J Integr Med. 2011 Mar;17(3):173-6. doi: 10.1007/s11655-011-0663-9. Epub 2011 Feb 27. Review.

PMID:
21359917
5.

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols.

Chan AW, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG.

BMJ. 2008 Dec 4;337:a2299. doi: 10.1136/bmj.a2299.

6.

In the dark: the reporting of blinding status in randomized controlled trials.

Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH.

J Clin Epidemiol. 2002 Aug;55(8):787-90.

PMID:
12384193
7.

Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000-2010.

Baethge C, Assall OP, Baldessarini RJ.

Psychother Psychosom. 2013;82(3):152-60. doi: 10.1159/000346144. Epub 2013 Mar 21. Review.

PMID:
23548796
8.

The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement.

Mills EJ, Wu P, Gagnier J, Devereaux PJ.

Contemp Clin Trials. 2005 Aug;26(4):480-7. Epub 2005 Mar 31.

PMID:
16054580
9.

Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.

Hróbjartsson A, Forfang E, Haahr MT, Als-Nielsen B, Brorson S.

Int J Epidemiol. 2007 Jun;36(3):654-63. Epub 2007 Apr 17.

10.

The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.

Gummesson C, Atroshi I, Ekdahl C.

J Hand Surg Am. 2004 Jul;29(4):727-34; discussion 735-7.

PMID:
15249101
11.

Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Kasenda B, Schandelmaier S, Sun X, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, Amstutz A, Bengough T, Meerpohl JJ, Stegert M, Olu KK, Tikkinen KA, Neumann I, Carrasco-Labra A, Faulhaber M, Mulla SM, Mertz D, Akl EA, Bassler D, Busse JW, Ferreira-González I, Lamontagne F, Nordmann A, Gloy V, Raatz H, Moja L, Rosenthal R, Ebrahim S, Vandvik PO, Johnston BC, Walter MA, Burnand B, Schwenkglenks M, Hemkens LG, Bucher HC, Guyatt GH, Briel M; DISCO Study Group.

BMJ. 2014 Jul 16;349:g4539. doi: 10.1136/bmj.g4539. Erratum in: BMJ. 2014;349:4921. Kasenda, Benjamin [added]; Schandelmaier, Stefan [added]; Sun, Xin [added]; von Elm, Erik [added]; You, John [added]; Blümle, Anette [added]; Tomonaga, Yuki (8) Saccilotto, Ramon (9) Amstutz, Alain [added]; Bengough, Theresa [added]; etc..

12.

Comparison of noninferiority margins reported in protocols and publications showed incomplete and inconsistent reporting.

Dekkers OM, Cevallos M, Bührer J, Poncet A, Ackermann Rau S, Perneger TV, Egger M.

J Clin Epidemiol. 2015 May;68(5):510-7. doi: 10.1016/j.jclinepi.2014.09.015. Epub 2014 Oct 22.

PMID:
25450451
13.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D.

Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030. doi: 10.1002/14651858.MR000030.pub2. Review.

PMID:
23152285
14.

Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.

Devereaux PJ, Manns BJ, Ghali WA, Quan H, Lacchetti C, Montori VM, Bhandari M, Guyatt GH.

JAMA. 2001 Apr 18;285(15):2000-3.

PMID:
11308438
15.

An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.

Devereaux PJ, Choi PT, El-Dika S, Bhandari M, Montori VM, Schünemann HJ, Garg AX, Busse JW, Heels-Ansdell D, Ghali WA, Manns BJ, Guyatt GH.

J Clin Epidemiol. 2004 Dec;57(12):1232-6.

PMID:
15617948
16.

Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.

Akl EA, Sun X, Busse JW, Johnston BC, Briel M, Mulla S, You JJ, Bassler D, Lamontagne F, Vera C, Alshurafa M, Katsios CM, Heels-Ansdell D, Zhou Q, Mills E, Guyatt GH.

J Clin Epidemiol. 2012 Mar;65(3):262-7. doi: 10.1016/j.jclinepi.2011.04.015. Epub 2011 Dec 24.

PMID:
22200346
17.

Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.

Boutron I, Guittet L, Estellat C, Moher D, Hróbjartsson A, Ravaud P.

PLoS Med. 2007 Feb;4(2):e61. Review.

18.

Association of trial registration with the results and conclusions of published trials of new oncology drugs.

Rasmussen N, Lee K, Bero L.

Trials. 2009 Dec 16;10:116. doi: 10.1186/1745-6215-10-116.

19.

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG.

JAMA. 2004 May 26;291(20):2457-65.

PMID:
15161896
20.

Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).

Brettschneider C, Lühmann D, Raspe H.

GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.

Items per page

Supplemental Content

Write to the Help Desk